VIRO 2026 – Global Voices in Renal Oncology
Highlights From VIRO 2026 – Global Voices in Renal Oncology, Day 1
Discussions Around the DeLLphi-305 Trial
MOB-RT Supports Moderate Hypofractionated Pelvic Radiotherapy in High-Risk Prostate Cancer
Hodgkin Lymphoma in 2026: What the New EHA Guidelines Recommend
Sevabertinib Moves Into First-Line HER2-Mutant NSCLC With FDA Accelerated Approval
Benjamin L. Ebert: A Major Step Forward for Personalized Cancer Vaccines
FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer
The WVOS 2026 Fall Conference, organized by the West Virginia Oncology Society (WVOS), will take place on October 22, 2026, at the Morgantown Marriott at Waterfront Place in Morgantown, West […]
